Network controllability analysis reveals the antiviral potential of Etravirine against Hepatitis E Virus infection
S. Ansari, D. T. Sarmah, R. Verma, K. Chandrasekar, S. Chatterjee, M. Surjit
This study identifies CK1ε as an antiviral target for HEV and shows that Etravirine, an HIV drug, inhibits CK1ε to exhibit antiviral activity against HEV.
bioRxiv · Jun 21, 2024 · PreprintMicrobiology